Cargando…
Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is the most common hematological malignancy in adult patients. Ferroptosis-related signatures have been shown to act as regulators of the progression of multiple cancer types, but the role of ferroptosis in AML remains to be elucidated. We performed the prese...
Autores principales: | Wei, Jie, Nai, Guan Ye, Dai, Yi, Huang, Xun Jun, Xiong, Ming Yue, Yao, Xiang You, Huang, Zhi Ning, Li, Si Nian, Zhou, Wei Jie, Huang, Yan, Cheng, Peng, Deng, Dong Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506534/ https://www.ncbi.nlm.nih.gov/pubmed/34733933 http://dx.doi.org/10.21037/atm-21-3368 |
Ejemplares similares
-
Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021) -
Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia
por: Li, Fenglin, et al.
Publicado: (2023) -
Analyzing the key gene expression and prognostics values for acute myeloid leukemia
por: Shi, Lingling, et al.
Publicado: (2020) -
MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia
por: Zhang, Lidan, et al.
Publicado: (2013) -
Expression signature of ten small nuclear RNAs serves as novel biomarker for prognosis prediction of acute myeloid leukemia
por: Zhang, Zhongming, et al.
Publicado: (2023)